Category: Pharma Industry

News Alert

AbbVie Puts Squeeze on 340B Pricing for Hospitals Akin to J&J and Amgen’s Recent Moves

In News Alert, Pharma IndustryMarch 29, 20231757 Views

AbbVie this morning significantly tightened its restrictions on 340B pricing for hospitals, along the lines of Amgen and Johnson & Johnson's recent moves.

Drug manufacturer AbbVie this morning significantly tightened its restrictions on 340B pricing for hospitals.

AbbVie has not yet responded to a request for comment about the changes. Non-hospital covered entities continue to be exempt from AbbVie’s pricing restrictions.

…

RWC-340B Opposes and Hemophilia Alliance Questions PhRMA and NACHC’s Push to Remake 340B

In Federal, Legislative, Pharma Industry, ProvidersMarch 28, 2023883 Views

Tom Mirga

RWC-340B rejected and Hemophilia Alliance criticized PhRMA and NACHC's joint plan to restructure the 340B program.

Ryan White Clinics for 340B Access has announced it opposes the drug industry’s joint plan with community health centers to restructure the 340B program, saying it will increase manufacturers’ “already astronomical profits at the expense of safety net

…

Confidential Document Fleshes Out ASAP 340B’s Reform Objectives

In Federal, Pharma Industry, ProvidersMarch 23, 20231732 Views

Tom Mirga

Excerpt from a confidential PhRMA principles document

PhRMA has written an eight-page document that elaborates on its principles for 340B program reform.

A confidential document composed by Pharmaceutical Research and Manufacturers of America in connection with its 340B program reform initiative with the National Association of Community Health Centers fleshes out a “coalition” vision of the 10-point reform plan that

…

340B Hospitals Say Pharma’s Contract Pharmacy Policies Are Costing Them “Billions of Dollars”

In Pharma Industry, Providers, Research/ReportsMarch 23, 2023526 Views

Tom Mirga

340B Hospital savings by drug company bar chart

340B Health says, "For just the first five of the 21 drug companies for which there is a full year of data post-restrictions, the 340B savings for hospitals decreased by an estimated $1.1 billion from 2020 to 2021."

Hospitals’ 340B savings for the first five of the 21 companies to impose conditions on 340B pricing when providers use contract pharmacies decreased by an estimated $1.1 billion from 2020 to 2021, hospital group 340B Health said in

…

PhRMA Discusses Joint 340B Reform Deal with Health Centers in Interview; Hospital Groups Denounce Plan

In Federal, Legislative, Pharma Industry, ProvidersMarch 21, 20231040 Views

Tom Mirga

“There is no way for 340B to be fixed without everybody coming to the table,” PhRMA spokesperson Nicole Longo said in an interview with 340B Report.

The fallout continues from drug makers and health centers’ decision to work together to change the 340B program, with the drug industry giving its first interview about the deal to 340B Report on Friday and several hospital groups

…

Amgen Expands 340B Contract Pharmacy Limits

In News Alert, Pharma IndustryMarch 17, 20232138 Views

Tom Mirga

Amgen today announced a major expansion of its conditions on 340B pricing when hospitals use contract pharmacies.

Biopharmaceutical manufacturer Amgen this afternoon significantly expanded its conditions on 340B pricing when hospitals use contract pharmacies.

Johnson & Johnson announced a similar expansion of its 340B contract pharmacy limits last month. Hospital groups slammed J&J’s new

…

Some Provider Groups Slam NACHC and PhRMA’s 340B Plan, Others Say They’re Studying it

In Federal, Legislative, News Alert, Pharma Industry, ProvidersMarch 10, 20231818 Views

Tom Mirga

Lt. Cmdr. Emeka Egwim (left), Director of HRSA's Office of Pharmacy Affairs, spoke this morning on 340B Day at NACHC's annual Policy & Issues Forum in Washington, D.C.

A large HIV/AIDS health care group, a Democratic 340B provider ally in Congress, and three national hospital groups lambasted community health centers and drug makers’ historic announcement yesterday that they are working together to remake the 340B program.

…

Major Drug Industry and Health Center Groups Unite to Reform 340B for Patients and “True” Safety-Net Providers

In Breaking, Federal, Legislative, Pharma Industry, ProvidersMarch 9, 20233751 Views

Tom Mirga

PhRMA, NACHC, and and the National Hispanic Medical Association created a new group, ASAP 340B, and issued a 10-point plan to ensure that the 340B program “benefits patients and true safety-net providers, including rural hospitals.”

Pharmaceutical Research and Manufacturers of America, the National Association of Community Health Centers, and the National Hispanic Medical Association this morning jointly issued a 10-point plan and created a nonprofit group to ensure that the 340B program “benefits

…

Amneal Offering 340B Refunds on Long List of Drugs for Sales Between Q3 2019 and Q3 2022

In Federal, Pharma Industry, RegulatoryMarch 9, 2023168 Views

Tom Mirga

Amneal Pharmaceuticals is offering refunds for 340B overcharges on an 18-page-long list of products for purchases between Q3 2019 and Q3 2022.

Generic and specialty drug manufacturer Amneal Pharmaceuticals is offering refunds for 340B overcharges on an 18-page-long list of products for purchases between Q3 2019 and Q3 2022.

The U.S. Health Resources and Services Administration posted New Jersey-based Amneal’s

…

Bottom Line, not Altruism, Could be the Main Driver of Lilly’s Insulin Price Cut, Drug Pricing Expert Says

In Federal, Pharma Industry, RegulatoryMarch 7, 2023717 Views

Tom Mirga

Lilly's decision to cut the price of its fast-acting insulin Humalog might have been driven by a desire to avoid exposure to Medicaid rebates, drug pricing expert Sean Dickson says.

Drug manufacturer Lilly’s announcement last week that it is slashing the price of Humalog, its most commonly prescribed insulin, may have been less about altruism and more about avoiding exposure to bigger Medicaid rebates, a prominent drug pricing

…

News Alert

News Alert

News Alert

Breaking News

Site Footer